Inhibition of α-ketoglutarate- and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions?

Journal of the American Aging Association

Volumn 21, Issue 1, 1998, Pages 25-30

  Cooper, Arthur J L ^a,c   Sheu, K F Rex ^a   Burke, James R ^b   Onodera, Osamu ^b   Strittmatter, Warren J ^b   Roses, Allen D ^b   Blass, John P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ESCHERICHIA COLI; GENE EXPRESSION; NEUROLOGIC DISEASE; NONHUMAN; TRINUCLEOTIDE REPEAT;

ESCHERICHIA COLI;

EID: 0032461376     PISSN: 01619152     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11357-998-0004-x     Document Type: Article

References (30)

1. Burke JR, Enghild JJ, Martin, ME, Jou Y-S, Myers RM, Roses AD, Vance JM and Strittmatter WJ. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2: 347-350, 1996.
2. Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT and Zoghbi HY. Spinocerebellar ataxia type-1 and spinocerebellar muscular atrophy gene products interact with glyceraldehyde-phosphate dehydrogenase. Human Mol. Gen. 5: 1311-1318, 1996.
3. Mangiarini L, Sathasivan K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies S W and Bates GP. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493-506, 1996.
4. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, Durr A, Didierjean O, Stevanini G, Agid Y and Brice A. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with sensitivity to expanded CAG/glutamine repeats. Nature Gen. 14: 285-291, 1996.
5. Lindblad K, Savontaus ML, Stevanin G, Holmberg M, Digre K, Zander C, Ehrsson H, David G, Benomar A, Nikoskelainen E, Trottier Y, Holmgren G, Ptacek LJ, Anttinen A, Brice A and Schalling M. An expanded CAG repeat sequence in spinocerebellar ataxia type 7. Genome Res. 6: 965-971, 1996.
6. Cooper AJL, Sheu K-FR, Onodera O, Burke JR, Stritmatter WJ. Roses AD and Blass JP. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and α-ketoglutarate dehydrogenase complex by poly-Q domains of pathological length. Proc. Natl. Acad. Sci. 94: 12604-12609, 1997.
7. Green H. Human genetic diseases due to codon reiteration: Relationship to an evolutionary mechanism. Cell 74: 955-956, 1993.
8. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumia S and Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Gen. 13: 196-202, 1996.
9. Kahlem P, Terré C, Green H and Djian P. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. U. S. A. 93: 14580-14585, 1996.
10. Cooper AJL, Sheu K-FR, Onodera O, Burke JR, Strittmatter WJ, Roses AD and Blass JP. Polyglutamine domains are substrates of tissue transglutaminase. Does transglutaminase play a role in expanded CAG/poly-Q repeat neurodegenerative diseases? J. Neurochem. 69: 431-434, 1997.
11. Stott K, Blackburn JM, Butler PJG and Perutz M. Incorporation of glutamine repeats makes protein oligomerize: Implications for neurodegerative diseases. Proc. Natl. Acad. Sci. U. S. A. 92: 6509-6513, 1995.
12. Chung SI. Comparative studies of tissue transglutaminase and factor XIII. Ann. N. Y. Acad. Sci. 202: 240-255, 1972.
13. Onodera O, Roses A, Tsuji S, Vance JM, Strittmatter WJ and Burke JR. Toxicity of expanded polyglutamine-domain proteins in Escherischia coli. FEBS Lett. 399, 135-139, 1996.
14. Folk JE and Cole PW. Transglutaminase: Mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim. Biophys. Chim. Acta 122: 244-264, 1966.
15. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
16. Gerber U, Jucknischke U, Putzien S and Fuchsbauer H-L. A rapid and simple method for the purification of transglutaminase from Streptoverticullum mobaraense. Biochem. J. 299: 825-829, 1994.
17. Ruiz-Herrera J, Iranzo M, Elorza MV, Sentanddreu R and Mormeneo S. Involvement of transglutaminase in the formation of covalent cross-links in the cell wall of Candida albicans. Arch. Microbiol. 164: 186-193, 1995.
18. Blass JP, Sheu RK-F, and Cederbaum JM. Energy metabolism in disorders of the nervous system. Rev. Neurol. (Paris) 144: 543-563, 1988.
19. Beal MF. Aging, energy metabolism, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38: 357-366, 1995.
20. Blass JP. Energy/glucose metabolism in neurodegenerative diseases. In: Molecular Mechanisms of Dementia (Wasco W, Tanzi RE, eds). Humana Press, NY. pp. 91-101, 1997.
21. Sorbi S, Bird ED, and Blass JP. Decreased pyruvate dehydrogenase complex activity in Huntintgton and Alzheimer brain. Ann. Neurol. 13: 72-78, 1983.
22. Mizuno Y, Ikebe S, Hattori N, Nakagawa-Hattori Y, Mochizuki H, Tanaka M, and Ozawa T. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim. Biophys. Acta 1271: 265-274, 1995.
23. Gibson GE, Sheu K-FR, Blass JP, Baker A, Carlson KC, Harding B, and Perion P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol. 45: 841-845, 1988.
24. Butterworth RF, and Besnard AM. Thiamine-dependent enzyme changes in the temporal cortex of patients with Alzheimer's disease. Metab. Brain. Dis. 5: 179-184, 1990.
25. Mastrogiacomo F, Lindsay JG, Bettendorf L, Rice J, and Kish SJ. Brian protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann. Neurol. 39: 592-598, 1996.
26. Sheu K-FR, Cooper AJL, Koike K, Koike M, Lindsay JG, and Blass JP. Abnormality of the α-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35: 312-318, 1994.
27. Blass JP, Sheu K-FR, Piacentini, S, and Sorbi, S. Inherent abnormalities in oxidative metabolism in Alzheimer disease: Interaction with vascular abnormalities. Ann. NY Acad. Sci. 826: 382-385, 1997.
28. Mastrogiacomo F, and Kish SJ. Cerebellar α-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type I. Ann. Neurol. 35: 624-626, 1994.
29. Mizuno Y, Matuda S, Yoshino H, Mori H, Hattori N, and Ikebe S. An immunohistochemical study of α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35: 204-210, 1994.
30. Sorbi S, Piacentini, Fani C, Tonini S, Marini P, and Amaducci L. Abnormalities of mitochondrial enzymes in hereditary ataxias. Acta Neurol. Scand. 80: 103-110, 1989.